Medicare

Home Nurse Inc Now Accepting Applications For SFC Medicaid Program In Atlanta

Retrieved on: 
Sunday, November 27, 2022

Home Nurse Inc has announced that its Structured Family Caregiving (SFC) Program is currently open to primary family caregivers in Atlanta.

Key Points: 
  • "Structured Family Caregiving (SFC) is a new Medicare service which offers coaching and financial support to primary caregivers," said Home Nurse Inc CEO Miranda Roberson, RN.
  • Lastly, the SFC program also has some specific criteria for the type of services that caregivers can provide to qualify for compensation.
  • As part of the SFC program, Home Nurse Inc will provide primary family caregivers with weekly compensation and health coaching from its team of nurses.
  • Led by Miranda Roberson, RN, Home Nurse Inc has partnered with a number of Georgia Medicaid Programs.

Amedisys Names Scott Ginn Acting Chief Operating Officer

Retrieved on: 
Tuesday, November 22, 2022

BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc.(NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately.

Key Points: 
  • BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc.(NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately.
  • Ginn has led financial teams at Amedisys since 2007, serving as Senior Vice President of Accounting and Controller and Chief Accounting Officer before being named Chief Financial Officer in 2017 and then being promoted to Executive Vice President in 2021.
  • As Acting Chief Operating Officer, Ginn will be responsible for all of Amedisys home health, hospice and personal care operations in addition to his current duties as Chief Financial Officer.
  • I am proud to step into this position and to continue to lead the company Ive had the privilege of serving for 15 years, stated Scott Ginn, Executive Vice President, Chief Financial Officer and Acting Chief Operating Officer.

Recora and Davis Health System Partner to Deliver Virtual Cardiac Recovery Program to Patients

Retrieved on: 
Tuesday, November 22, 2022

NEW YORK & ELKINS, W.V., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Recora today announced it has been selected by Davis Health System for its Virtual Cardiac Recovery Program.

Key Points: 
  • NEW YORK & ELKINS, W.V., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Recora today announced it has been selected by Davis Health System for its Virtual Cardiac Recovery Program.
  • Recora's Cardiac Recovery Program moves beyond 12 weeks of rehabilitation to deliver comprehensive care management that focuses on a patient's overall health and wellness.
  • Recora currently serves cardiac patients in the U.S. across health systems, health plans and medical groups in urban, suburban and rural communities.
  • Recora's Cardiac Recovery Program for health systems, medical groups and health plans makes it easier to recover from a cardiac event through immersive programs delivered online.

Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection

Retrieved on: 
Monday, November 21, 2022

NASHUA, N.H., Nov. 21, 2022 (GLOBE NEWSWIRE) --  iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new and real-world research demonstrating the value of its Breast AI Suite will be highlighted at the Radiological Society of North America (RSNA) Annual Meeting in Chicago, November 27 to December 1. The Company is also showcasing this technology in booth #4754 at the meeting.  

Key Points: 
  • Companys Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools showcased at largest medical imaging forum in the world
    NASHUA, N.H., Nov. 21, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc .
  • Not only is our Breast AI Suite clinically proven to improve radiologists performance, but more importantly, it is uniquely enhancing patient care and improving lives.
  • Represented on a scale of 0 to 100%, Case Scores represent the algorithms relative confidence that a lesion is malignant.
  • Study findings suggest radiologists using ProFound AI should consider changes in Case Scores over sequential screens, as larger increases may indicate an increased likelihood of screen-detected cancer.

Alignment Health Plan Joins Forces With the American Diabetes Association to Promote Diabetes Awareness

Retrieved on: 
Monday, November 21, 2022

ORANGE, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) insurance carrier from Alignment Health, and the American Diabetes Association® (ADA) have renewed their partnership to educate and empower the Alignment community with tools and resources for diabetes self-management.

Key Points: 
  • At Alignment, we put seniors first by providing the resources they need to proactively manage their health, especially for those affected by multiple chronic health conditions, including diabetes, said Dr. Dinesh Kumar, chief medical and operating officer at Alignment Health.
  • The American Diabetes Association is excited for this ongoing partnership with Alignment Health Plan to support those living with diabetes, said Dr. Laura Hieronymus, vice president, Health Care Programs, for the ADA.
  • The American Diabetes Association (ADA) is the nations leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive.
  • Join the fight with us on Facebook ( American Diabetes Association ), Spanish Facebook ( Asociacin Americana de la Diabetes ),LinkedIn ( American Diabetes Association ), Twitter ( @AmDiabetesAssn ), andInstagram ( @AmDiabetesAssn ).

MagArray, Inc. Announces the Publication of Knodule ID Clinical Validation Results in CHEST

Retrieved on: 
Monday, November 21, 2022

The article, titled Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors, presents data suggesting that Knodule ID may offer a significant improvement over using the Mayo Clinic Model alone to characterize indeterminate nodules.

Key Points: 
  • The article, titled Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors, presents data suggesting that Knodule ID may offer a significant improvement over using the Mayo Clinic Model alone to characterize indeterminate nodules.
  • Knodule ID is MagArrays second lung nodule characterization test following the REVEAL test, which is already covered by Medicare.
  • From our CLIA-certified lab located in Milpitas, CA, we offer the Knodule ID and REVEAL Lung Nodule Characterization tests.
  • Clinicians and patients interested in gaining access to REVEAL or Knodule ID should call 619.738.3251, email [email protected] or request information from the companys website at www.magarray.com

Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Sunday, November 20, 2022

Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

FLGT DEADLINE ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – FLGT

Retrieved on: 
Friday, November 18, 2022

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

InvestmentPitch Media Video Discusses Reliq Health, a Rapidly Growing Global Healthcare Technology Company, and its Contract to add 15 Skilled Nursing Facilities to its iUGO Care Platform

Retrieved on: 
Friday, November 18, 2022

Dr. Lisa Crossley, CEO, stated: We are very pleased to be expanding into the Skilled Nursing Facility market in California.

Key Points: 
  • Dr. Lisa Crossley, CEO, stated: We are very pleased to be expanding into the Skilled Nursing Facility market in California.
  • A Skilled Nursing Facility provides transitional care, which is covered under Medicare for a limited time after a qualifying hospital stay.
  • In 2019, approximately 1.5 million Medicare patients received care at approximately 15,000 skilled nursing facilities.
  • InvestmentPitch Media Ltd makes no warranties or undertakings as to the accuracy or completeness of this information.

As Medicare Advantage plans increase in popularity, it pays for consumers to understand their coverage options

Retrieved on: 
Thursday, November 17, 2022

In 2022, 28.4 millionAmericans were enrolled in Medicare Advantage plans 48% of all Medicare beneficiaries.

Key Points: 
  • In 2022, 28.4 millionAmericans were enrolled in Medicare Advantage plans 48% of all Medicare beneficiaries.
  • The Congressional Budget Office projects that by 2032, 61% of Medicare beneficiaries will be enrolled in Medicare Advantage plans.
  • During Medicare open enrollment, Medicare beneficiaries who are already enrolled in Medicare coverage have a handful of decisions regarding their coverage.
  • Prescription drug costs: Most Medicare Advantage plans include Medicare Part D drug coverage, but ifyoure considering an Advantage plan,you should check it to make sure.